Using fecal microbiota transplantation to treat digestive and related diseases
The Safety and Efficacy of Fecal Microbiota Transplantation in the Treatment of Digestive Diseases and Non-digestive System Diseases Associated With Gastrointestinal Symptoms in the Gastrointestinal Tract.
NA · Shanghai 10th People's Hospital · NCT06208930
This study is testing if a treatment that involves transplanting healthy gut bacteria can help people with digestive issues and related health problems feel better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 10000 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Shanghai 10th People's Hospital (other) |
| Locations | 1 site (Shanghai, Shanghai) |
| Trial ID | NCT06208930 on ClinicalTrials.gov |
What this trial studies
This study investigates the safety and efficacy of fecal microbiota transplantation (FMT) for treating digestive diseases and non-digestive conditions that present with gastrointestinal symptoms. The research aims to optimize the FMT process and identify the most effective treatment methods to enhance therapeutic outcomes. Participants will undergo FMT while their symptoms and overall health will be monitored to assess improvements across various systems.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who can tolerate a nasoenteric tube or swallow a capsule and are experiencing gastrointestinal symptoms.
Not a fit: Patients with intestinal barrier dysfunction or those unable to tolerate enteral nutrition may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a novel treatment option for patients suffering from a range of digestive and related diseases.
How similar studies have performed: Other studies have shown promising results with fecal microbiota transplantation, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being able to tolerate a nasoenteric tube or swallow a capsule. Exclusion Criteria: * Intestinal barrier dysfunction. Inability to tolerate enteral nutrition.
Where this trial is running
Shanghai, Shanghai
- Le Wang — Shanghai, Shanghai, China (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Fecal Microbiota Transplantation